- Nymox Pharmaceutical Corporation(NASDAQ: NYMX) tumbled 63.9% to close at $0.4555 on Monday after the company received a #Refusal to File letter from the FDA regarding the company's New Drug Application for fexapotide triflutate.
EOSE sold on 09/30/2024 gained 101.03 buy back 2.68 20 share on 10/01/2024 gained= 5 $